“…ErbB/ Her genes are often mutated or have altered expression in cancer and precancerous cells, which is often a sign of progression and development of disease (Vogt et al, 1998;Xu et al, 2002;Awaya et al, 2005;Saxby et al, 2005;Sassen et al, 2008). ErbB/Her aberrations have also been reported in some types of endocrine lesions, e.g., of thyroid, pheochromocytoma and pancreas (Sworczak et al, 2002;Freudenberg et al, 2005;Saxby et al, 2005;Lee et al, 2007). ErbB-1/Her-1/EGFR expression has been found in pHPT-related adenomas and hyperplasia (Sadler et al, 1996;Gülkesen et al, 2001) and, interestingly, recent data have documented an involvement of its activation in the initiation of parathyroid hyperplasia as a consequence of secondary hyperparathyroidism (Cozzolino et al, 2005).…”